Herspiegel is known for our medical affairs expertise that supports Medical Affairs teams in consistently providing value to patients, physicians, and payers. We specialize in identifying education gaps, raising awareness of the science underlying disease states, and speeding the translation of this information to clinical practice through comprehensive learning opportunities. Herspiegel is a dependable thought partner for medical affairs strategy development and can provide teams with innovative tactical planning tailored to the needs of a diversity of experts in many therapeutic areas.
Collected detailed insights and developed medical objectives and strategic plans that aligned to a portfolio strategy and commercialization critical success factors and strategic imperatives.
Built a comprehensive and well-referenced strategic resource of key medical messages and developed an asset-specific internal resource of cross-functionally aligned terms and phrases.
Worked with internal Medical Affairs teams and external KOL speakers to develop symposia content, as well as event fliers and postcards for conferences and medical meetings.
Developed attendee list, planned agenda and built content for meetings with top thought leaders to identify insights and strategic direction.
Developed innovative medical affairs tactics aligned to objectives to raise awareness of new MOA and commonly misdiagnosed disease state by assessing the medical landscape and providing tools and training to the MSL team.
Developed medical affairs strategic objectives with accompanying tactical plans and detailed budget estimates.
The FDA is developing a framework for a new Real-World Evidence (RWE) Program to guide the generation of data in support of approval for in-line indications. Read our white paper to learn how the pharmaceutical industry will be impacted.
